China, India, Other Poor Nations Target Of GSK Tropical-Disease Move
This article was originally published in PharmAsia News
Executive Summary
China and India are among nations that could benefit from an effort by U.K.-based GlaxoSmithKline to make drugs to treat tropical diseases in the world's poorest countries